KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Construction in Progress (2016 - 2025)

HCA Healthcare (HCA) has disclosed Construction in Progress for 16 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Construction in Progress rose 15.45% to $2.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 15.45% increase, with the full-year FY2025 number at $2.1 billion, up 15.45% from a year prior.
  • Construction in Progress was $2.1 billion for Q4 2025 at HCA Healthcare, up from $1.9 billion in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $2.1 billion in Q4 2025 to a low of $1.4 billion in Q4 2021.
  • A 5-year average of $1.8 billion and a median of $1.9 billion in 2024 define the central range for Construction in Progress.
  • Peak YoY movement for Construction in Progress: dropped 7.22% in 2021, then increased 26.6% in 2022.
  • HCA Healthcare's Construction in Progress stood at $1.4 billion in 2021, then grew by 26.6% to $1.8 billion in 2022, then rose by 6.49% to $1.9 billion in 2023, then dropped by 0.64% to $1.9 billion in 2024, then rose by 15.45% to $2.1 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Construction in Progress are $2.1 billion (Q4 2025), $1.9 billion (Q4 2024), and $1.9 billion (Q4 2023).